Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
R03AL11	BREZTRI AEROSPHERE	B	Formoterol fumarate dihydrate - 5mcg, Glycopyrronium Bromide - 7.2mcg, Budesonide - 160mcg		Inhalation suspension	6,705,774 L.L
R03BA02	BUDENA	G	Budesonide - 50mcg/actuation	50mcg/actuation	Inhalation suspension	823,775 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 1mg/2ml	1mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 1mg/2ml	1mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
J01MA23	BAXDELA	B	Delafloxacin - 300mg	300mg	Injectable concentrate for solution	78,349,010 L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	97,176,574 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	142,487,946 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	47,495,416 L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrate for solution	41,821,582 L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	1,593,932 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	2,400,006 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	799,993 L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrate for solution	685,976 L.L
M05BA06	BONDRONAT	B	Ibandronic acid (monosodium monohydrate) - 6mg/6ml	6mg/6ml	Injectable concentrated powder for solution	24,963,868 L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	26,072,618 L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrated solution	41,821,582 L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrated solution	685,976 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	21,602,799 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	21,602,799 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	5,738,697 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	35,076,021 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,163,958 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,552,784 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	776,308 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	3,928,126 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE ACCORD	G	Bendamustine HCl - 25mg/10ml	25mg/10ml	Injectable powder for concentrate for solution	11,186,776 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (25mg)	2.5mg/ml	Injectable powder for concentrate for solution	10,405,803 L.L

...